Partnering with Oakwood

Oakwood is actively seeking collaborations with companies with either currently marketed products or products in development that could be enhanced by a sustained release injectable dosage form.

Oakwood has also developed certain generic or soon-to-be generic compounds into novel dosage forms which are available for licensing.

Oakwood Labs is interested in knowing how we can help. Please consider taking a few moments and completing our questionnaire.

For more information contact:
Mark T. Smith
msmith@oakwoodlabs.com
Tel: (440) 359-0000
Fax: (440) 359-0001


Oakwood Labs

Oakwood Laboratories was founded as the research division of Ben Venue Laboratories, the largest and most experienced parenteral company in the world. In 1997 it was spun off as a separate entity when Ben Venue was acquired by Boehringer-Ingelheim. Oakwood's founders, Edward C. Smith and Mark T. Smith were C.E.O and the Director of Business Development of Ben Venue and were responsible for starting Ben Venue's generic division, Bedford Laboratories.